# A New Diagnostic Method to Assess Paclitaxel-Induced Peripheral Neuropathy

> **NCT04237194** · — · UNKNOWN · sponsor: **Carsten Dahl Mørch** · enrollment: 20 (estimated)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04237194
- **Lead sponsor:** Carsten Dahl Mørch
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04237194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04237194, "A New Diagnostic Method to Assess Paclitaxel-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04237194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*